StockMarketWire.com - Collagen Solutions said it remained 'positive' about its outlook and was on track with its key initiatives for the year.

The core business was experiencing continued growth as expected to support our goal of further improvement on overall financial performance in line with market expectations, the company said.

'We are engaged in active dialogue with our notified body regarding our application for CE marking ChondroMimetic, consistent with our plan to resolve open questions in time to gain approval in the financial year, while the response time or additional questions by the notified body still cannot be guaranteed,' Jamal Rushdy, CEO of Collagen Solutions, said in prepared remarks.

'Finally, our global R&D team is executing on several key customer product development projects supporting a strong pipeline of contract manufacturing over the next several years.'


At 10:14am: [LON:COS] Collagen Solutions Plc share price was 0p at 3.75p



Story provided by StockMarketWire.com